We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

402340:KRXSK Square Co., Ltd. Analysis

Data as of 2026-06-07 - not real-time

₩1,258,000.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

SK Square is trading at a sharp discount to its intrinsic estimate, with the current price of 1,258,000 KRW well below the DCF‑derived fair value of 2,728,907 KRW and an implied upside of roughly 9%. Its forward P/E of 3.79 is dramatically lower than the industry average of 32.56, underscoring the valuation gap. The company boasts exceptional profitability – gross margin near 98% and ROE above 54% – and generates robust cash flow, evidenced by free cash flow exceeding 9.9 trillion KRW. Technicals remain bullish: the price sits above the 20‑, 50‑ and 200‑day SMAs, RSI is at a comfortable 63, and the support level at 983,000 KRW provides a solid floor. However, the MACD histogram is marginally negative and the beta of 2.16 signals heightened sensitivity to market swings, while 30‑day volatility approaches 90%. Dividend yield is only 0.12% with a zero payout ratio, suggesting limited income appeal. Analyst sentiment is strongly positive, with 11 analysts assigning a “strong buy” rating and target prices averaging around 1.37 million KRW.
Given the combination of deep valuation discount, strong earnings power, and bullish price action, the short‑ to medium‑term outlook is favorable, but investors should remain mindful of sector cyclicality and the stock’s elevated market risk.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above key moving averages (20/50/200 SMA)
  • RSI in moderate range indicating room for upside
  • Support level provides downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap to DCF fair value
  • Strong earnings margins and cash generation
  • Analyst consensus of strong‑buy with elevated target prices

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • High ROE and near‑perfect gross margin suggest durable competitive advantage
  • Exposure to global semiconductor demand growth
  • Undervalued relative to peers despite sector volatility

Key Metrics & Analysis

Financial Health

Revenue Growth318.80%
Profit Margin91.56%
P/E Ratio3.8
ROE54.39%
ROA31.10%
Debt/Equity0.33
Op. Cash Flow₩411.4B
Free Cash Flow₩9921.3B
Industry P/E32.6

Technical Analysis

TrendBullish
RSI63.3
Support₩983,000.00
Resistance₩1,392,000.00
MA 20₩1,181,150.00
MA 50₩864,940.00
MA 200₩470,561.00
MACDBearish
VolumeStable
Fear & Greed Index83.02

Valuation

Fair Value₩2,728,907.33
Target Price₩1,368,181.90
Upside/Downside8.76%
GradeUndervalued
TypeGrowth
Dividend Yield0.12%

Risk Assessment

Beta2.16
Volatility89.42%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.